SNAP-8 | CAS:868844-74-0

We serve SNAP-8 CAS:868844-74-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
SNAP-8

Chemical Name:SNAP-8
CAS.NO:868844-74-0
Synonyms:SNAP-8
N-Acetyl-L-alpha-glutamyl-L-alpha-glutamyl-L-methionyl-L-glutaminyl-L-arginyl-L-arginyl-L-alanyl-L-alpha-asparagine
Acetyl Octapeptide-3
Acetyl Glutamyl Heptapeptide-3
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Molecular Formula C41H70N16O16S
Molecular Weight 1075.157
Index of Refraction 1.665
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Acetyl Glutamyl Heptapeptide-3 or Acetyl Octapeptide-1 (or -3) (SNAP-8) is scientifically and reasonablely designed of anti-wrinkle active ingredients of polypeptide. It has a similar role to Areginine Essence and has become one of the most popular raw materials around the world for upscale anti-wrinkle cosmetics.



Contact us for information like SNAP-8 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetyl Octapeptide-3 Use and application,N-Acetyl-L-alpha-glutamyl-L-alpha-glutamyl-L-methionyl-L-glutaminyl-L-arginyl-L-arginyl-L-alanyl-L-alpha-asparagine technical grade,usp/ep/jp grade.


Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Methyl 2-bromohexanoate manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Ethyl 1-hydroxy-1H-1,2,3-triazole-4-carboxylate supplier This is how an API becomes a medicine.3,5-Dichloro-2,4,6-trifluoropyridine vendor This is how an API becomes a medicine.This is how an API becomes a medicine.